 Susana Arrigain
Concepts (363)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Renal Insufficiency, Chronic | 31 | 2023 | 586 | 2.790 |
Why?
| | Glomerular Filtration Rate | 22 | 2023 | 681 | 0.990 |
Why?
| | Lung Transplantation | 8 | 2023 | 263 | 0.930 |
Why?
| | Kidney Transplantation | 8 | 2023 | 576 | 0.860 |
Why?
| | Registries | 23 | 2021 | 1806 | 0.760 |
Why?
| | Kidney Failure, Chronic | 10 | 2021 | 514 | 0.620 |
Why?
| | Proportional Hazards Models | 18 | 2023 | 1124 | 0.490 |
Why?
| | Cause of Death | 8 | 2018 | 379 | 0.440 |
Why?
| | Acute Kidney Injury | 6 | 2023 | 705 | 0.400 |
Why?
| | Waiting Lists | 4 | 2023 | 228 | 0.390 |
Why?
| | Middle Aged | 50 | 2021 | 27510 | 0.380 |
Why?
| | Living Donors | 6 | 2023 | 318 | 0.380 |
Why?
| | Aged | 44 | 2020 | 19594 | 0.380 |
Why?
| | Body Mass Index | 7 | 2020 | 2074 | 0.380 |
Why?
| | Male | 70 | 2021 | 57474 | 0.360 |
Why?
| | Health Expenditures | 2 | 2022 | 173 | 0.350 |
Why?
| | Tissue Donors | 3 | 2021 | 334 | 0.350 |
Why?
| | Female | 69 | 2022 | 61261 | 0.350 |
Why?
| | Aged, 80 and over | 22 | 2019 | 6541 | 0.330 |
Why?
| | Electronic Health Records | 7 | 2017 | 809 | 0.310 |
Why?
| | Ohio | 10 | 2017 | 140 | 0.310 |
Why?
| | Renal Dialysis | 7 | 2018 | 377 | 0.300 |
Why?
| | Risk Factors | 24 | 2023 | 8958 | 0.290 |
Why?
| | Kaplan-Meier Estimate | 10 | 2021 | 840 | 0.290 |
Why?
| | Kidney Diseases | 4 | 2011 | 439 | 0.290 |
Why?
| | Humans | 80 | 2023 | 118251 | 0.280 |
Why?
| | Retrospective Studies | 27 | 2023 | 12929 | 0.260 |
Why?
| | Patient Navigation | 2 | 2017 | 77 | 0.260 |
Why?
| | Kidney | 7 | 2021 | 1351 | 0.250 |
Why?
| | Follow-Up Studies | 13 | 2020 | 4574 | 0.240 |
Why?
| | United States | 18 | 2022 | 12488 | 0.240 |
Why?
| | Body Height | 1 | 2005 | 186 | 0.240 |
Why?
| | Graft Survival | 3 | 2021 | 497 | 0.240 |
Why?
| | Health Services Accessibility | 3 | 2020 | 776 | 0.230 |
Why?
| | Knee Injuries | 1 | 2005 | 103 | 0.230 |
Why?
| | Transplant Recipients | 3 | 2021 | 148 | 0.230 |
Why?
| | Nephrology | 2 | 2021 | 50 | 0.230 |
Why?
| | Nephrologists | 1 | 2023 | 13 | 0.230 |
Why?
| | Travel | 2 | 2020 | 115 | 0.220 |
Why?
| | Donor Selection | 2 | 2021 | 73 | 0.220 |
Why?
| | Anterior Cruciate Ligament Injuries | 1 | 2005 | 147 | 0.220 |
Why?
| | Time Factors | 14 | 2021 | 6368 | 0.210 |
Why?
| | Nutrition Surveys | 4 | 2021 | 232 | 0.210 |
Why?
| | Obesity | 5 | 2016 | 2715 | 0.210 |
Why?
| | Risk Assessment | 11 | 2021 | 3043 | 0.210 |
Why?
| | Adult | 27 | 2023 | 31324 | 0.200 |
Why?
| | Stomach Diseases | 1 | 2021 | 17 | 0.200 |
Why?
| | Disease Progression | 9 | 2021 | 2477 | 0.200 |
Why?
| | Histamine H2 Antagonists | 1 | 2021 | 31 | 0.200 |
Why?
| | Transplants | 1 | 2021 | 36 | 0.190 |
Why?
| | Insulin Resistance | 3 | 2020 | 1167 | 0.190 |
Why?
| | Severity of Illness Index | 8 | 2019 | 2659 | 0.190 |
Why?
| | Proteinuria | 1 | 2021 | 99 | 0.190 |
Why?
| | Comorbidity | 8 | 2021 | 1516 | 0.190 |
Why?
| | Proton Pump Inhibitors | 1 | 2021 | 98 | 0.190 |
Why?
| | Extracorporeal Membrane Oxygenation | 1 | 2023 | 241 | 0.190 |
Why?
| | Body Weight | 1 | 2005 | 923 | 0.190 |
Why?
| | Age Factors | 9 | 2021 | 2990 | 0.180 |
Why?
| | Abdominal Fat | 1 | 2020 | 48 | 0.180 |
Why?
| | Ventricular Function, Left | 3 | 2019 | 468 | 0.180 |
Why?
| | Nephrectomy | 1 | 2021 | 162 | 0.180 |
Why?
| | Heart Transplantation | 2 | 2021 | 672 | 0.180 |
Why?
| | Magnesium | 1 | 2020 | 150 | 0.180 |
Why?
| | Chi-Square Distribution | 7 | 2016 | 524 | 0.170 |
Why?
| | Hypertension | 5 | 2017 | 1199 | 0.170 |
Why?
| | Cohort Studies | 11 | 2020 | 5078 | 0.170 |
Why?
| | Career Choice | 1 | 2021 | 192 | 0.170 |
Why?
| | Internal Medicine | 1 | 2021 | 215 | 0.170 |
Why?
| | Mortality | 2 | 2018 | 297 | 0.170 |
Why?
| | Propensity Score | 5 | 2020 | 242 | 0.170 |
Why?
| | Stroke Volume | 2 | 2019 | 513 | 0.160 |
Why?
| | Treatment Outcome | 14 | 2021 | 9319 | 0.160 |
Why?
| | Terminology as Topic | 1 | 2019 | 199 | 0.160 |
Why?
| | Resource Allocation | 1 | 2018 | 38 | 0.160 |
Why?
| | Immunologic Factors | 1 | 2020 | 224 | 0.160 |
Why?
| | Graft Rejection | 4 | 2021 | 548 | 0.160 |
Why?
| | Medicaid | 1 | 2022 | 411 | 0.160 |
Why?
| | Program Evaluation | 2 | 2021 | 838 | 0.160 |
Why?
| | Hypernatremia | 1 | 2017 | 9 | 0.150 |
Why?
| | Gout Suppressants | 1 | 2017 | 33 | 0.150 |
Why?
| | Health Records, Personal | 1 | 2017 | 24 | 0.150 |
Why?
| | Cholesterol, HDL | 1 | 2018 | 198 | 0.150 |
Why?
| | Heart Valve Prosthesis | 1 | 2019 | 125 | 0.150 |
Why?
| | Hyponatremia | 1 | 2017 | 42 | 0.150 |
Why?
| | Sex Factors | 5 | 2021 | 1765 | 0.150 |
Why?
| | Cardiac Surgical Procedures | 3 | 2007 | 458 | 0.150 |
Why?
| | Health Care Costs | 1 | 2020 | 390 | 0.150 |
Why?
| | Transcatheter Aortic Valve Replacement | 1 | 2019 | 151 | 0.140 |
Why?
| | Logistic Models | 7 | 2015 | 1896 | 0.140 |
Why?
| | Incidence | 6 | 2021 | 2413 | 0.140 |
Why?
| | Creatinine | 3 | 2023 | 491 | 0.140 |
Why?
| | Inflammatory Bowel Diseases | 1 | 2020 | 290 | 0.140 |
Why?
| | Hyperuricemia | 1 | 2017 | 133 | 0.140 |
Why?
| | Contrast Media | 1 | 2018 | 373 | 0.140 |
Why?
| | Diabetic Nephropathies | 2 | 2017 | 288 | 0.130 |
Why?
| | Vascular Resistance | 2 | 2015 | 356 | 0.130 |
Why?
| | Hypokalemia | 1 | 2015 | 31 | 0.130 |
Why?
| | Diet, Reducing | 1 | 2015 | 83 | 0.130 |
Why?
| | Hyperkalemia | 1 | 2015 | 24 | 0.130 |
Why?
| | Catheters | 1 | 2015 | 61 | 0.130 |
Why?
| | Aortic Valve Stenosis | 1 | 2019 | 296 | 0.130 |
Why?
| | Program Development | 2 | 2015 | 355 | 0.130 |
Why?
| | Adipokines | 1 | 2014 | 43 | 0.130 |
Why?
| | Multivariate Analysis | 7 | 2016 | 1469 | 0.120 |
Why?
| | Delivery of Health Care, Integrated | 1 | 2017 | 230 | 0.120 |
Why?
| | Electric Countershock | 1 | 2015 | 110 | 0.120 |
Why?
| | Patient Selection | 1 | 2018 | 670 | 0.120 |
Why?
| | Patient Acceptance of Health Care | 1 | 2020 | 683 | 0.120 |
Why?
| | Blood Pressure | 3 | 2017 | 1656 | 0.120 |
Why?
| | Uric Acid | 1 | 2017 | 349 | 0.120 |
Why?
| | Chelating Agents | 1 | 2014 | 70 | 0.120 |
Why?
| | Atrial Fibrillation | 1 | 2018 | 338 | 0.120 |
Why?
| | Death, Sudden, Cardiac | 1 | 2015 | 166 | 0.120 |
Why?
| | Patient Education as Topic | 2 | 2017 | 696 | 0.120 |
Why?
| | Odds Ratio | 4 | 2014 | 993 | 0.120 |
Why?
| | Primary Prevention | 1 | 2015 | 183 | 0.120 |
Why?
| | Phosphates | 1 | 2014 | 166 | 0.110 |
Why?
| | Lung Diseases | 1 | 2019 | 709 | 0.110 |
Why?
| | Arrhythmias, Cardiac | 1 | 2015 | 277 | 0.110 |
Why?
| | Bronchiolitis Obliterans | 2 | 2010 | 66 | 0.110 |
Why?
| | Alkaline Phosphatase | 1 | 2013 | 158 | 0.110 |
Why?
| | Ultrasonography, Doppler, Duplex | 1 | 2012 | 39 | 0.110 |
Why?
| | Bariatric Surgery | 1 | 2014 | 166 | 0.100 |
Why?
| | Prognosis | 6 | 2018 | 3424 | 0.100 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 3 | 2016 | 1130 | 0.100 |
Why?
| | Carotid Stenosis | 1 | 2012 | 75 | 0.100 |
Why?
| | Exercise Therapy | 1 | 2015 | 355 | 0.100 |
Why?
| | Hypoglycemic Agents | 2 | 2010 | 1031 | 0.100 |
Why?
| | Follicular Fluid | 1 | 2011 | 8 | 0.100 |
Why?
| | Defibrillators, Implantable | 1 | 2015 | 299 | 0.100 |
Why?
| | Sperm Injections, Intracytoplasmic | 1 | 2011 | 8 | 0.100 |
Why?
| | Bicarbonates | 1 | 2011 | 44 | 0.100 |
Why?
| | Ventricular Dysfunction, Left | 1 | 2015 | 374 | 0.100 |
Why?
| | Sunscreening Agents | 1 | 2011 | 16 | 0.100 |
Why?
| | Coronary Disease | 2 | 2016 | 355 | 0.100 |
Why?
| | Diabetes Mellitus, Type 2 | 3 | 2010 | 2159 | 0.100 |
Why?
| | Internship and Residency | 1 | 2021 | 1005 | 0.100 |
Why?
| | Stents | 2 | 2012 | 457 | 0.100 |
Why?
| | Survival Rate | 4 | 2019 | 1716 | 0.100 |
Why?
| | Infertility | 1 | 2011 | 45 | 0.100 |
Why?
| | Blood Flow Velocity | 1 | 2012 | 327 | 0.100 |
Why?
| | Motivation | 1 | 2015 | 502 | 0.100 |
Why?
| | Testosterone | 1 | 2014 | 350 | 0.090 |
Why?
| | Adipose Tissue | 1 | 2014 | 595 | 0.090 |
Why?
| | Hepatitis, Autoimmune | 1 | 2010 | 33 | 0.090 |
Why?
| | Triglycerides | 1 | 2012 | 515 | 0.090 |
Why?
| | Chronic Disease | 6 | 2011 | 1630 | 0.090 |
Why?
| | Young Adult | 7 | 2021 | 10731 | 0.090 |
Why?
| | Inflammation | 1 | 2020 | 2545 | 0.090 |
Why?
| | Health Surveys | 1 | 2011 | 453 | 0.090 |
Why?
| | Vitamin D Deficiency | 1 | 2011 | 161 | 0.090 |
Why?
| | Cytomegalovirus Infections | 2 | 2009 | 187 | 0.090 |
Why?
| | Motor Activity | 1 | 2014 | 664 | 0.090 |
Why?
| | Quality of Health Care | 1 | 2014 | 585 | 0.090 |
Why?
| | Reactive Oxygen Species | 1 | 2011 | 571 | 0.080 |
Why?
| | Metabolic Syndrome | 1 | 2013 | 392 | 0.080 |
Why?
| | Orthotic Devices | 1 | 2008 | 30 | 0.080 |
Why?
| | Elasticity | 1 | 2009 | 192 | 0.080 |
Why?
| | Asthma | 1 | 2021 | 2143 | 0.080 |
Why?
| | Insurance, Health | 2 | 2022 | 244 | 0.080 |
Why?
| | Splenorenal Shunt, Surgical | 1 | 2007 | 6 | 0.080 |
Why?
| | Liver Cirrhosis | 1 | 2010 | 243 | 0.080 |
Why?
| | Vitamin D | 1 | 2011 | 352 | 0.080 |
Why?
| | Gait Disorders, Neurologic | 1 | 2008 | 40 | 0.080 |
Why?
| | Brachial Artery | 1 | 2009 | 180 | 0.080 |
Why?
| | Mycoses | 1 | 2008 | 68 | 0.080 |
Why?
| | Cytomegalovirus | 2 | 2009 | 144 | 0.080 |
Why?
| | Practice Patterns, Physicians' | 2 | 2014 | 1197 | 0.080 |
Why?
| | Veterans | 1 | 2018 | 1212 | 0.080 |
Why?
| | Esophageal and Gastric Varices | 1 | 2007 | 40 | 0.080 |
Why?
| | Portasystemic Shunt, Transjugular Intrahepatic | 1 | 2007 | 39 | 0.080 |
Why?
| | Hip Joint | 1 | 2008 | 144 | 0.070 |
Why?
| | Gastrointestinal Hemorrhage | 1 | 2007 | 107 | 0.070 |
Why?
| | Diabetic Angiopathies | 1 | 2009 | 261 | 0.070 |
Why?
| | Attitude of Health Personnel | 2 | 2021 | 990 | 0.070 |
Why?
| | Medical Staff | 1 | 2006 | 16 | 0.070 |
Why?
| | Staff Development | 1 | 2006 | 38 | 0.070 |
Why?
| | Arachidonate 5-Lipoxygenase | 1 | 2006 | 43 | 0.070 |
Why?
| | Heart Failure | 4 | 2016 | 1967 | 0.070 |
Why?
| | Prospective Studies | 5 | 2022 | 6443 | 0.070 |
Why?
| | Diskectomy | 1 | 2005 | 20 | 0.070 |
Why?
| | Splanchnic Circulation | 1 | 2005 | 10 | 0.070 |
Why?
| | Complementary Therapies | 1 | 2006 | 71 | 0.070 |
Why?
| | Mesenteric Artery, Superior | 1 | 2005 | 12 | 0.070 |
Why?
| | Adolescent | 8 | 2021 | 18364 | 0.070 |
Why?
| | Problem-Based Learning | 1 | 2006 | 82 | 0.070 |
Why?
| | Survival Analysis | 4 | 2010 | 1262 | 0.070 |
Why?
| | Intervertebral Disc | 1 | 2005 | 37 | 0.070 |
Why?
| | Intervertebral Disc Displacement | 1 | 2005 | 39 | 0.070 |
Why?
| | Ileostomy | 1 | 2005 | 18 | 0.060 |
Why?
| | Proctocolectomy, Restorative | 1 | 2005 | 19 | 0.060 |
Why?
| | Health Status | 2 | 2021 | 723 | 0.060 |
Why?
| | Education, Medical, Continuing | 1 | 2006 | 124 | 0.060 |
Why?
| | Hyperthermia, Induced | 1 | 2005 | 67 | 0.060 |
Why?
| | Astrocytoma | 1 | 2006 | 112 | 0.060 |
Why?
| | Tissue and Organ Procurement | 2 | 2018 | 247 | 0.060 |
Why?
| | Poisson Distribution | 1 | 2005 | 68 | 0.060 |
Why?
| | Oxidative Stress | 1 | 2011 | 1167 | 0.060 |
Why?
| | Hypoplastic Left Heart Syndrome | 1 | 2005 | 112 | 0.060 |
Why?
| | Anterior Cruciate Ligament | 1 | 2005 | 89 | 0.060 |
Why?
| | Low Back Pain | 1 | 2005 | 100 | 0.060 |
Why?
| | Health Knowledge, Attitudes, Practice | 2 | 2017 | 1183 | 0.060 |
Why?
| | Cardiology | 1 | 2006 | 272 | 0.060 |
Why?
| | Lung | 1 | 2016 | 3623 | 0.060 |
Why?
| | Multiple Sclerosis | 1 | 2008 | 384 | 0.060 |
Why?
| | Models, Biological | 1 | 2010 | 1701 | 0.060 |
Why?
| | Waist Circumference | 2 | 2014 | 130 | 0.060 |
Why?
| | Analysis of Variance | 2 | 2020 | 1288 | 0.060 |
Why?
| | Urinalysis | 1 | 2023 | 68 | 0.060 |
Why?
| | Hypertension, Pulmonary | 1 | 2014 | 1784 | 0.050 |
Why?
| | Pneumonia | 1 | 2008 | 579 | 0.050 |
Why?
| | Ambulatory Care Facilities | 2 | 2017 | 216 | 0.050 |
Why?
| | Catheter Ablation | 1 | 2005 | 286 | 0.050 |
Why?
| | Laboratories | 1 | 2023 | 96 | 0.050 |
Why?
| | Microscopy | 1 | 2023 | 124 | 0.050 |
Why?
| | Relative Value Scales | 1 | 2021 | 5 | 0.050 |
Why?
| | Work-Life Balance | 1 | 2021 | 9 | 0.050 |
Why?
| | Contraceptive Agents | 1 | 2022 | 56 | 0.050 |
Why?
| | Biomarkers | 3 | 2020 | 3567 | 0.050 |
Why?
| | Angiotensin-Converting Enzyme Inhibitors | 2 | 2015 | 194 | 0.050 |
Why?
| | ROC Curve | 3 | 2008 | 470 | 0.050 |
Why?
| | Diabetes Mellitus | 3 | 2016 | 939 | 0.050 |
Why?
| | Ultrasonography, Doppler | 2 | 2015 | 104 | 0.050 |
Why?
| | Vegetables | 1 | 2021 | 132 | 0.050 |
Why?
| | Case-Control Studies | 2 | 2020 | 3156 | 0.050 |
Why?
| | Predictive Value of Tests | 3 | 2012 | 1857 | 0.050 |
Why?
| | Insurance Coverage | 1 | 2022 | 208 | 0.050 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2006 | 1161 | 0.050 |
Why?
| | Antihypertensive Agents | 2 | 2017 | 436 | 0.050 |
Why?
| | United States Public Health Service | 1 | 2019 | 8 | 0.050 |
Why?
| | Postoperative Complications | 3 | 2006 | 2230 | 0.040 |
Why?
| | Clinical Clerkship | 1 | 2021 | 98 | 0.040 |
Why?
| | Health Services Needs and Demand | 2 | 2015 | 251 | 0.040 |
Why?
| | Mentors | 1 | 2021 | 165 | 0.040 |
Why?
| | Sulfonylurea Compounds | 2 | 2010 | 44 | 0.040 |
Why?
| | Injections, Intra-Arterial | 1 | 2018 | 25 | 0.040 |
Why?
| | Injections, Intravenous | 1 | 2018 | 209 | 0.040 |
Why?
| | Adiposity | 2 | 2014 | 508 | 0.040 |
Why?
| | Cross-Sectional Studies | 3 | 2016 | 4521 | 0.040 |
Why?
| | Child | 6 | 2021 | 19033 | 0.040 |
Why?
| | Linear Models | 1 | 2020 | 817 | 0.040 |
Why?
| | Brain Neoplasms | 1 | 2006 | 1019 | 0.040 |
Why?
| | Acute Disease | 2 | 2010 | 933 | 0.040 |
Why?
| | Blood Pressure Determination | 1 | 2017 | 133 | 0.040 |
Why?
| | Child, Preschool | 3 | 2021 | 9448 | 0.040 |
Why?
| | Coronary Angiography | 1 | 2018 | 311 | 0.040 |
Why?
| | Echocardiography | 1 | 2019 | 556 | 0.030 |
Why?
| | Survivors | 2 | 2009 | 411 | 0.030 |
Why?
| | beta 2-Microglobulin | 1 | 2015 | 46 | 0.030 |
Why?
| | Prevalence | 2 | 2013 | 2321 | 0.030 |
Why?
| | Recovery of Function | 1 | 2019 | 603 | 0.030 |
Why?
| | Cystatin C | 1 | 2015 | 69 | 0.030 |
Why?
| | Protective Factors | 1 | 2016 | 90 | 0.030 |
Why?
| | Smoking | 2 | 2016 | 1478 | 0.030 |
Why?
| | Sensitivity and Specificity | 2 | 2011 | 1787 | 0.030 |
Why?
| | Blood Glucose | 2 | 2015 | 1936 | 0.030 |
Why?
| | Lumbosacral Region | 1 | 2015 | 50 | 0.030 |
Why?
| | Angiotensin Receptor Antagonists | 1 | 2015 | 84 | 0.030 |
Why?
| | Potassium | 1 | 2015 | 132 | 0.030 |
Why?
| | Absorptiometry, Photon | 1 | 2015 | 226 | 0.030 |
Why?
| | Aortic Valve | 1 | 2019 | 402 | 0.030 |
Why?
| | United States Department of Veterans Affairs | 1 | 2018 | 556 | 0.030 |
Why?
| | Statistics, Nonparametric | 2 | 2006 | 400 | 0.030 |
Why?
| | Quality Indicators, Health Care | 1 | 2017 | 295 | 0.030 |
Why?
| | Equipment Failure | 1 | 2015 | 114 | 0.030 |
Why?
| | Respiratory Function Tests | 1 | 2016 | 526 | 0.030 |
Why?
| | Glucose Tolerance Test | 1 | 2015 | 361 | 0.030 |
Why?
| | Personnel Selection | 1 | 2015 | 71 | 0.030 |
Why?
| | Drug Utilization Review | 1 | 2014 | 60 | 0.030 |
Why?
| | Leptin | 1 | 2015 | 228 | 0.030 |
Why?
| | Diet | 1 | 2021 | 1143 | 0.030 |
Why?
| | Exercise Tolerance | 1 | 2015 | 234 | 0.030 |
Why?
| | Phosphorus | 1 | 2014 | 84 | 0.030 |
Why?
| | Adiponectin | 1 | 2015 | 224 | 0.030 |
Why?
| | Pulmonary Wedge Pressure | 1 | 2014 | 65 | 0.030 |
Why?
| | Hypogonadism | 1 | 2014 | 77 | 0.030 |
Why?
| | Surveys and Questionnaires | 2 | 2021 | 4684 | 0.030 |
Why?
| | Prosthesis Design | 1 | 2015 | 285 | 0.030 |
Why?
| | C-Reactive Protein | 1 | 2015 | 364 | 0.030 |
Why?
| | Arterial Pressure | 1 | 2014 | 99 | 0.030 |
Why?
| | Glucose Metabolism Disorders | 1 | 2013 | 12 | 0.030 |
Why?
| | Life Style | 1 | 2015 | 431 | 0.030 |
Why?
| | Medicare | 1 | 2018 | 664 | 0.030 |
Why?
| | Hyperparathyroidism | 1 | 2012 | 12 | 0.030 |
Why?
| | Hypoalbuminemia | 1 | 2012 | 27 | 0.030 |
Why?
| | Anthropometry | 1 | 2012 | 192 | 0.030 |
Why?
| | Arthritis, Rheumatoid | 1 | 2020 | 990 | 0.030 |
Why?
| | Hemoglobins | 1 | 2014 | 318 | 0.030 |
Why?
| | Body Composition | 1 | 2015 | 644 | 0.030 |
Why?
| | Hospitalization | 1 | 2020 | 1778 | 0.020 |
Why?
| | Dyslipidemias | 1 | 2013 | 162 | 0.020 |
Why?
| | Length of Stay | 2 | 2006 | 1027 | 0.020 |
Why?
| | Emergency Service, Hospital | 1 | 2021 | 1848 | 0.020 |
Why?
| | Glipizide | 1 | 2010 | 6 | 0.020 |
Why?
| | Glyburide | 1 | 2010 | 36 | 0.020 |
Why?
| | Regression Analysis | 1 | 2012 | 984 | 0.020 |
Why?
| | Heart-Lung Transplantation | 1 | 2009 | 11 | 0.020 |
Why?
| | Healthcare Disparities | 1 | 2015 | 494 | 0.020 |
Why?
| | Lipids | 1 | 2013 | 591 | 0.020 |
Why?
| | Educational Status | 1 | 2011 | 437 | 0.020 |
Why?
| | Seasons | 1 | 2011 | 461 | 0.020 |
Why?
| | Tomography, X-Ray Computed | 1 | 2018 | 2433 | 0.020 |
Why?
| | Cyclosporine | 1 | 2009 | 173 | 0.020 |
Why?
| | North America | 1 | 2009 | 265 | 0.020 |
Why?
| | Europe | 1 | 2009 | 355 | 0.020 |
Why?
| | Tacrolimus | 1 | 2009 | 149 | 0.020 |
Why?
| | Calcium | 1 | 2014 | 1151 | 0.020 |
Why?
| | Kidney Function Tests | 1 | 2008 | 163 | 0.020 |
Why?
| | Thiazolidinediones | 1 | 2009 | 146 | 0.020 |
Why?
| | Coronary Artery Bypass | 1 | 2009 | 210 | 0.020 |
Why?
| | Longitudinal Studies | 1 | 2014 | 2491 | 0.020 |
Why?
| | Quality-Adjusted Life Years | 1 | 2007 | 103 | 0.020 |
Why?
| | Reference Values | 1 | 2009 | 770 | 0.020 |
Why?
| | Antioxidants | 1 | 2011 | 564 | 0.020 |
Why?
| | Primary Health Care | 1 | 2017 | 1539 | 0.020 |
Why?
| | Dialysis | 1 | 2006 | 24 | 0.020 |
Why?
| | Negativism | 1 | 2006 | 3 | 0.020 |
Why?
| | Salvage Therapy | 1 | 2007 | 130 | 0.020 |
Why?
| | Equipment Design | 1 | 2008 | 518 | 0.020 |
Why?
| | Religion and Psychology | 1 | 2006 | 26 | 0.020 |
Why?
| | HL-60 Cells | 1 | 2006 | 28 | 0.020 |
Why?
| | Cardiovascular Diseases | 1 | 2018 | 1795 | 0.020 |
Why?
| | Secondary Prevention | 1 | 2007 | 227 | 0.020 |
Why?
| | Range of Motion, Articular | 1 | 2008 | 369 | 0.020 |
Why?
| | Cerebrovascular Disorders | 1 | 2006 | 86 | 0.020 |
Why?
| | Peripheral Vascular Diseases | 1 | 2006 | 98 | 0.020 |
Why?
| | Morbidity | 1 | 2006 | 293 | 0.020 |
Why?
| | Muscle Strength | 1 | 2008 | 283 | 0.020 |
Why?
| | Activities of Daily Living | 1 | 2008 | 353 | 0.020 |
Why?
| | Gait | 1 | 2008 | 253 | 0.020 |
Why?
| | Enterocolitis, Necrotizing | 1 | 2005 | 27 | 0.020 |
Why?
| | Metformin | 1 | 2009 | 293 | 0.020 |
Why?
| | Surgical Stapling | 1 | 2005 | 9 | 0.020 |
Why?
| | Immunosuppressive Agents | 1 | 2009 | 682 | 0.020 |
Why?
| | Cardiopulmonary Bypass | 1 | 2006 | 199 | 0.020 |
Why?
| | Quality of Life | 1 | 2015 | 2355 | 0.020 |
Why?
| | Cost-Benefit Analysis | 1 | 2007 | 551 | 0.020 |
Why?
| | Anastomosis, Surgical | 1 | 2005 | 146 | 0.020 |
Why?
| | Patient Satisfaction | 1 | 2008 | 609 | 0.020 |
Why?
| | Perioperative Care | 1 | 2005 | 131 | 0.020 |
Why?
| | Histological Techniques | 1 | 2004 | 43 | 0.020 |
Why?
| | Tumor Cells, Cultured | 1 | 2006 | 871 | 0.020 |
Why?
| | Neoplasms | 1 | 2018 | 2160 | 0.010 |
Why?
| | Teaching | 1 | 2006 | 235 | 0.010 |
Why?
| | Suture Techniques | 1 | 2005 | 134 | 0.010 |
Why?
| | Delivery of Health Care | 1 | 2010 | 862 | 0.010 |
Why?
| | Viremia | 1 | 2004 | 127 | 0.010 |
Why?
| | Pain Measurement | 1 | 2005 | 468 | 0.010 |
Why?
| | Intensive Care Units, Neonatal | 1 | 2005 | 178 | 0.010 |
Why?
| | Viral Load | 1 | 2004 | 406 | 0.010 |
Why?
| | Hospital Mortality | 1 | 2006 | 811 | 0.010 |
Why?
| | Evidence-Based Medicine | 1 | 2006 | 690 | 0.010 |
Why?
| | Pilot Projects | 1 | 2006 | 1405 | 0.010 |
Why?
| | Bronchoalveolar Lavage Fluid | 1 | 2004 | 605 | 0.010 |
Why?
| | Immunohistochemistry | 1 | 2004 | 1681 | 0.010 |
Why?
| | Myocardial Infarction | 1 | 2006 | 967 | 0.010 |
Why?
| | Pregnancy | 1 | 2011 | 5671 | 0.010 |
Why?
| | Pneumonia, Viral | 1 | 2004 | 347 | 0.010 |
Why?
| | RNA, Messenger | 1 | 2006 | 2657 | 0.010 |
Why?
| | Cells, Cultured | 1 | 2006 | 4044 | 0.010 |
Why?
| | Infant | 1 | 2010 | 8254 | 0.010 |
Why?
| | Infant, Newborn | 1 | 2005 | 5230 | 0.010 |
Why?
| | Brain | 1 | 2006 | 2481 | 0.010 |
Why?
|
|
Arrigain's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|